Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLAM.L Regulatory News (LAM)

  • There is currently no data for LAM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Move to Main Market

8 Oct 2008 07:00

RNS Number : 3233F
Lamprell plc
08 October 2008
 



Lamprell plc 

Proposed move from AIM to Main Market 

Lamprell plc ("Lamprell" or "the Company" and together with its subsidiaries the "Group"), announces that it intends to apply for admission to listing of its ordinary shares ("Ordinary Shares") on the Official List of the UK Listing Authority (the "Official List") and admission to trading on the London Stock Exchange's main market for listed securities (the "Main Market") (together "the Admission"). 

The Admission will be effected by an introduction of Lamprell's existing Ordinary Shares with no new Ordinary Shares being issued. Pursuant to Rule 41 of the AIM Rules for Companies, the Company hereby gives notice of the intended cancellation of trading of its Ordinary Shares on the AIM market of the London Stock Exchange ("AIM"). The Company announced on 13 February 2008 that it intended to move from AIM to the Main Market. 

It is expected that the cancellation of trading in the Ordinary Shares on AIM will take place at the same time as the Ordinary Shares are admitted to the Official List and begin trading on the Main Market, which is expected to occur on or around 6 November 2008, subject to receipt of the necessary approvals from the UK Listing Authority and the London Stock Exchange. 

JPMorgan Cazenove Limited has been appointed as sole sponsor in relation to the Admission and will be acting as sole broker to the Company. 

For further information: 

Lamprell plc +44 (0) 207 153 1547

Peter Birch, Chairman

Peter Whitbread, Chief Executive Officer 

Scott Doak, Chief Financial Officer

David Moran, Director of Corporate Communications

JPMorgan Cazenove, London +44 (0) 207 588 2828

Malcolm Moir 

Nick Garrett

Laurence Hollingworth

M:Communications, London

Patrick d'Ancona +44 (0) 207 153 1547

Charlotte Kirkham  +44 (0) 207 153 1531

Georgina Briscoe +44 (0) 207 153 1548

This announcement is an advertisement and not a prospectus and investors should not subscribe for or purchase any securities referred to in this announcement except on the basis of information in the prospectus to be published by the Company ("the Prospectus") in due course in connection with the Admission. Copies of the Prospectus will, following publication, be available from the offices of Freshfields Bruckhaus Deringer LLP 65 Fleet StreetLondon EC4Y 1HS.  

 

The Company is not offering any new Ordinary Shares or other securities in connection with the Admission. This document does not constitute an offer to sell, or the solicitation of an offer to subscribe for or buy Ordinary Shares or other securities in any jurisdiction. 

 

The contents of this announcement have been prepared by and are the sole responsibility of the Company. JPMorgan Cazenove Limited who is authorised and regulated in the United Kingdom by the FSA has been appointed as Sponsor to the Company. JPMorgan Cazenove is advising the Company and no-one else in connection with Admission and will not be responsible to anyone other than the Company for providing the protections afforded to the clients of JPMorgan Cazenove or for giving advice in relation to the Admission, the contents of this announcement or any transaction or arrangement referred to herein.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUBABRWSRRRAA
Date   Source Headline
6th Jul 20217:00 amRNSHolding(s) in Company
29th Jun 20216:08 pmRNS2020 Annual Report and Accounts
29th Jun 20217:00 amRNS2020 Financial Results
15th Jun 20217:00 amRNSUpdate to release date of 2020 financial results
13th May 20217:00 amRNSUpdate to release date of 2020 Financial Results
28th Apr 20211:28 pmRNSNew Contract Award
23rd Apr 20217:00 amRNSUpdate to release date of 2020 Financial Results
30th Mar 20217:00 amRNSInjazat and Lamprell announce joint venture
8th Mar 20217:00 amRNSRevised date for full year results
24th Feb 20218:00 amRNSNew Contract Award
1st Feb 20217:00 amRNSPDMR Shareholdings
21st Jan 20218:12 amRNSHolding(s) in Company
18th Jan 20217:00 amRNSHolding(s) in Company
14th Jan 20217:00 amRNSStrategic Re-organisation and Trading Update
20th Nov 20207:00 amRNSHolding(s) in Company
12th Nov 20209:09 amRNSUpdate on IMI joint venture
5th Nov 20207:00 amRNSHolding(s) in Company
2nd Nov 20207:00 amRNSNew Contract Award
5th Oct 20207:00 amRNSDirector/PDMR Shareholding
1st Oct 20207:00 amRNS2020 Interim Results
3rd Sep 202010:37 amRNSHolding(s) in Company
22nd Jul 20207:00 amRNSTrading Update
25th Jun 20204:05 pmRNSResult of AGM 2020
24th Jun 202012:02 pmRNSHolding(s) in Company
23rd Jun 20202:27 pmRNSUpdate on Seagreen contract award
15th Jun 20204:36 pmRNSPrice Monitoring Extension
5th Jun 20204:02 pmRNSNew Contract Award
27th May 20207:00 amRNSNotice of AGM/Annual Report and Accounts
20th May 20204:41 pmRNSSecond Price Monitoring Extn
20th May 20204:35 pmRNSPrice Monitoring Extension
20th May 20207:00 amRNSNew Contract Award
13th May 20207:00 amRNS2019 Full Year Results
5th May 20202:49 pmRNSUpdated release date of the 2019 Financial Results
4th May 20207:00 amRNSHolding(s) in Company
23rd Apr 20201:42 pmRNSEast Anglia One - final contract settlement
14th Apr 20207:00 amRNSUpdate on restructuring/Covid19 self-help measures
8th Apr 20204:35 pmRNSPrice Monitoring Extension
24th Mar 20204:38 pmRNSPrice Monitoring Extension
23rd Mar 20207:36 amRNSUpdated release date of the 2019 financial results
20th Mar 20204:45 pmRNSSecond Price Monitoring Extn
20th Mar 20204:38 pmRNSPrice Monitoring Extension
17th Mar 20204:43 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
12th Mar 20204:41 pmRNSSecond Price Monitoring Extn
12th Mar 20204:36 pmRNSPrice Monitoring Extension
9th Mar 20207:00 amRNSDirector/PDMR Shareholding
12th Feb 20207:00 amRNSDigital collaboration with Akselos
10th Feb 20207:00 amRNSDirectorate Change
20th Jan 20207:00 amRNSNew Contract Award
16th Jan 20207:00 amRNSPre-close Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.